Medication use by middle-aged and older participants of an exercise study: results from the Brain in Motion study

Tania Pannu, Sarah Sharkey, Grazyna Burek, Daniela Cretu, Michael D Hill, David B Hogan, Marc J Poulin, Tania Pannu, Sarah Sharkey, Grazyna Burek, Daniela Cretu, Michael D Hill, David B Hogan, Marc J Poulin

Abstract

Background: Over the past 50 years, there has been an increase in the utilization of prescribed, over-the-counter (OTC) medications, and natural health products. Although it is known that medication use is common among older persons, accurate data on the patterns of use, including the quantity and type of medications consumed in a generally healthy older population from a Canadian perspective are lacking. In this study, we study the pattern of medication use in a sedentary but otherwise healthy older persons use and determined if there was an association between medication use and aerobic fitness level.

Methods: All participants enrolled in the Brain in Motion study provided the name, formulation, dosage and frequency of any medications they were consuming at the time of their baseline assessment. Maximal aerobic capacity (VO2max) was determined on each participant.

Results: Two hundred seventy one participants (mean age 65.9 ± 6.5 years; range 55-92; 54.6% females) were enrolled. Most were taking one or more (1+) prescribed medication (n = 204, 75.3%), 1+ natural health product (n = 221, 81.5%) and/or 1+ over-the-counter (OTC) drug (n = 174, 64.2%). The most commonly used prescribed medications were HMG-CoA reductase inhibitors (statins) (n = 52, 19.2%). The most common natural health product was vitamin D (n = 201, 74.2%). For OTC drugs, non-steroidal anti-inflammatories (n = 82, 30.3%) were the most common. Females were more likely than males to take 1+ OTC medications, as well as supplements. Those over 65 years of age were more likely to consume prescription drugs than their counterparts (p ≤ 0.05). Subjects taking more than two prescribed or OTC medications were less physically fit as determined by their VO2max. The average daily Vitamin D intake was 1896.3 IU per participant.

Conclusions: Medication use was common in otherwise healthy older individuals. Consumption was higher among females and those older than 65 years. Vitamin D intake was over two-fold higher than the recommended 800 IU/day for older persons, but within the tolerable upper intake of 4,000 IU/day. The appropriateness of the high rate of medication use in this generally healthy population deserves further investigation.

Keywords: Geriatrics; Natural Health Products; Polypharmacy; Prescription drugs.

Figures

Fig. 1
Fig. 1
Flow chart outlining the phases of the BIM study. Medication use was obtained at the time of baseline assessment (Pre-intervention Phase 1A)

References

    1. Canada’s Physical Activity Guide to Healthy Active Living for Older Adults. . Accessed June 2014.
    1. Gorelick PB, Sacco RL, Smith DB, Alberts M, Mustone-Alexander L, Rader D, Ross JL, Raps E, Ozer MN, Brass LM, Malone ME, Goldberg S, Booss J, Hanley DF, Toole JF, Greengold NL, Rhew DC. Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the national stroke association. J Am Med Assoc. 1999;281(12):1112–1120. doi: 10.1001/jama.281.12.1112.
    1. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol. 2001;58(3):498–504. doi: 10.1001/archneur.58.3.498.
    1. Bishop NA, Lu T, Yankner BA. Neural mechanisms of ageing and cognitive decline. Nature. 2010;464(7288):529–535. doi: 10.1038/nature08983.
    1. Canadian Institute for Health Information . Drivers of Prescription Drug Spending in Canada. Ottawa, ON: CIHI; 2012.
    1. Rotermann M, Sanmartin C, Hennessy D, Arthur M. Prescription medication use by Canadians aged 6 to 79. Statistics Canada, Catalogue no.: 82-003-X. Health Rep. 2014;25(6):3–9.
    1. Morgan S, Smolina K, Mooney D, Raymond C, Bowen M, Gorczynski C, et al. The Canadian Rx Atlas. 3. Vancouver: Centre for Health Services and Policy Research, University of British Columbia; 2013.
    1. Ramage-Morin PL. Medication use among senior Canadians. Health Rep. 2009;20(1):37–44.
    1. Mo F, Morrison H, Liepold H, Underhill L. Drug utilization in Canadian patients with major chronic diseases. Am J Pharm Benefits. 2011;3(3):e42–e50.
    1. Nahin RL, Pecha M, Welmerink DB, Sink K, DeKosky ST, Fitzpatrick AL. Concomitant use of prescription drugs and dietary supplements in ambulatory elderly people. J Am Geriatr Soc. 2009;57(7):1197–1205. doi: 10.1111/j.1532-5415.2009.02329.x.
    1. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300(24):2867–2878. doi: 10.1001/jama.2008.892.
    1. Tyndall AV, Davenport MH, Wilson BJ, Burek GM, Arsenault-Lapierre G, Haley E, et al. The brain-in-motion study: effect of a 6-month aerobic exercise intervention on cerebrovascular regulation and cognitive function in older adults. BMC Geriatr. 2013;13:21. doi: 10.1186/1471-2318-13-21.
    1. Paterson DH, Cunningham DA, Koval JJ, St. Croix CM. Aerobic fitness in a population of independently living men and women aged 55–86 years. Med Sci Sports Exerc. 1999;31(12):1813–1820. doi: 10.1097/00005768-199912000-00018.
    1. Canadian Society for Exercise Physiology . Professional Fitness and Lifestyle Consultant: Resource Manual, Canadian Society for Exercise Physiology. Ottawa: Canadian Society for Exercise Physiology; 1996.
    1. Anonymous ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211–277. doi: 10.1164/rccm.167.2.211.
    1. Butler-Jones D. The Chief Public Health Officer's Report on the State of Public Health in Canada, 2009: Growing older - Adding life to years. Ottawa, ON: Public Health Agency of Canada; 2009. p. 2010.
    1. Canadian Institute for Health Information . Drug Expenditure in Canada, 1985 to 2012. Ottawa, ON: CIHI; 2013.
    1. Canadian Institute for Health Information. Drug Use Among Seniors on Public Drug Programs in Canada, 2012: Revised October 2014.
    1. Bailey RL, Gahche JJ, Miller PE, Thomas PR, Dwyer JT. Why US Adults Use Dietary Supplements. JAMA Intern Med. 2013;173(5):355–361. doi: 10.1001/jamainternmed.2013.2299.
    1. Steiner M. Effect of alpha-tocopherol administration on platelet function in man. Thromb Haemost. 1983;49(2):73–77.
    1. Celestini A, Pulcinelli FM, Pignatelli P, Lenti L, Frati G, Gazzaniga PP, et al. Vitamin E potentiates the antiplatelet activity of aspirin in collagen-stimulated platelets. Haematologica. 2002;87(4):420–426.
    1. Gonzalez-Correa JA, Arrebola MM, Guerrero A, Muñoz-Marín J, Ruiz-Villafranca D, Sánchez de La Cuesta F, et al. Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood. Platelets. 2005;16(3-4):171–179. doi: 10.1080/09537100400016797.
    1. Crowe M, Wollner L, Griffiths RA. Hypercalcaemia following vitamin D and thiazide therapy in the elderly. Practitioner. 1984;228(1389):312–313.
    1. Drinka PJ, Nolten WE. Hazards of treating osteoporosis and hypertension concurrently with calcium, vitamin D, and distal diuretics. J Am Geriatr Soc. 1984;32(5):405–407. doi: 10.1111/j.1532-5415.1984.tb02050.x.
    1. Parfitt AM. Thiazide-induced hypercalcemia in vitamin D-treated hypoparathyroidism. Ann Intern Med. 1972;77(4):557–563. doi: 10.7326/0003-4819-77-4-557.
    1. Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol. 2004;22:2489–2503. doi: 10.1200/JCO.2004.08.182.
    1. Brazier NC, Levine MA. Drug–herb interaction among commonly used conventional medicines: a compendium for health care professionals. Am J Ther. 2003;10:163–169. doi: 10.1097/00045391-200305000-00003.
    1. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009;69:1777–1798. doi: 10.2165/11317010-000000000-00000.
    1. Mehta DH, Gardiner PM, Phillips RS, McCarthy EP. Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions. J Altern Complement Med. 2008;14:1263–1269. doi: 10.1089/acm.2008.0290.
    1. Shord SS, Shah K, Lukose A. Drug–botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals. Integr Cancer Ther. 2009;8(3):208–227.
    1. Gurley BJ, Swain A, Hubbard MA, et al. Clinical assessment of CYP2D6-mediated herb–drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John’s wort, and Echinacea. Mol Nutr Food Res. 2008;52:755–763. doi: 10.1002/mnfr.200600300.
    1. Chen XW, Serag ES, Sneed KB, Liang J, Chew H, Pan SY, et al. Clinical Herbal Interactions with Conventional Drugs: From Molecules to Maladies. Curr Med Chem. 2011;18:4836–4850. doi: 10.2174/092986711797535317.
    1. Hu Z, Yang X, Ho PCL, Chan SY, Heng PWS, Chan E, et al. Herb-Drug Interactions: A literature Review. Drugs. 2005;65(9):1239–1282. doi: 10.2165/00003495-200565090-00005.
    1. Atkin PA, Veitch PC, Veitch EM, Ogle SJ. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging. 1999;14(2):141–152. doi: 10.2165/00002512-199914020-00005.
    1. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56(2):163–184. doi: 10.1124/pr.56.2.4.
    1. Heft MW, Mariotti AJ. Geriatric pharmacology. Dent Clin North Am. 2002;46(4):869–885. doi: 10.1016/S0011-8532(02)00025-3.
    1. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38(2):303–312. doi: 10.1345/aph.1D252.
    1. Janz T, Pearson C. Vitamin D blood levels of Canadians, health at a glance. Statistics Canada, Catalogue no.: 82-624-X. 2013. . Accessed 19 Sept 2015.
    1. Barr SI, Green TJ. Vitamin D supplement use by adult Canadians: sociodemographic correlates. FASEB J. 2013;27:1059.4.
    1. Hanley DA, Cranney A, Jones G, Whiting SJ, Leslie WD, Cole DE, et al. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ. 2010;182(12):e610–e618. doi: 10.1503/cmaj.080663.
    1. Bolland MJ, Grey A, Gamble GD, Reid IR. Vitamin D supplementation and falls: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2014;2(7):573–580. doi: 10.1016/S2213-8587(14)70068-3.
    1. Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet. 2014;383(9912):146–155. doi: 10.1016/S0140-6736(13)61647-5.
    1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. doi: 10.1210/jc.2011-0385.
    1. Judge J, Birge S, Gloth F, Heaney R, Hollis B, Kenny A, et al. Recommendations abstracted from the American geriatrics society consensus statement on vitamin D for prevention of falls and their consequences. J Am Geriatr Soc. 2014;62(1):147–152. doi: 10.1111/jgs.12631.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner